CLINICAL_TRIALS
trial_result
· 2020-12-23
Clinical Trial Update: Safety and Efficacy Study in Adult Subjects With Acute Migraines [Phase 3]
Summary
Phase 3 safety and efficacy study in adults with acute migraines has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Migraine, With or Without Aura | Phase 3 | Status: COMPLETED | Results posted: 2020-12-23